TIXEL I
PRINCIPLE
FDA Cleared
Introducing Tixel-i: an eye opening relief
A 2-minute treatment for Dry Eye Disease with no expression needed. Best in class results and longer lasting relief with proven safety.
Major Reduction in Symptoms
OSDI (Ocular Surface Disease Index)
OSDI scores range from 0-100, with lower scores indicating fewer symptoms. Scores above 33 indicate severe dry eye disease.
Improved Tear Retention
TBUT (Tear Break-Up Time, seconds)
TBUT measures tear film stability. Higher values indicate better tear film stability. A TBUT of 10 seconds or more is generally considered normal.
Don’t take our word for it
Tixel has been clinically validated in many peer-reviewed studies
FEATURES
Industry-first capabilities for Dry Eye Disease
- Effective
Patients report significant relief for months after treatment - Fast
Three quick two-minute treatments. Two weeks apart - Simple
Incredibly easy to use, light to carry, fits in every clinic - Proven
Thoroughly researched and studied across the globe - Versatile
Effective on all skin types - Cost Effective
Zero disposables and fast patient turn-around